The three sides agreed that the trilateral initiative will serve as a forum to promote the design and execution of cooperation projects in ...

Companies such as Gilead, Eli Lilly and Regeneron have worked on novel treatments, either from their own labs or by reviving molecules that...

This week, global drugmakers Pfizer and BioNTech said their COVID-19 vaccine candidate is 95 per cent effective, including in adults over 6...

The WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight market and to...

The move gains significance as global drug makers involved in the development of Covid therapeutics have refused to give up patents over th...

Leena Menghaney, a lawyer with MSF India, told ET that it is critical for governments to address this global crisis as they did nearly 20 y...

In a landmark development, global biopharmaceutical company Sanofi will lower the price of Rifapentine, a critically important drug used to...

The company introduced 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the ...

Member States adopted a new political declaration to fast-track progress towards combating the epidemic over the next five years and eradic...

The organisation works on accelerating development and delivery of affordable diagnostic tests for poverty-related diseases.

Cipla and Strides will develop a product building on the clinical studies led by TDR, the special programme for research and training in tr...

Aurobindo Pharma Chief Executive Officer said the new licence would help ensure the timely introduction of generic ATV in developing countr...

An independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...

If the European Union does not allow Indian drugs to transit through its customs even after bilateral negotiations, India will drag Brussel...

Government on Friday said granting of patents to HIV/AIDS drugs might increase cost of the medicines and create problems for patients, alth...

A new agreement has been clinched with pharmaceutical firms to substantially decrease the cost of treating AIDS in 66 countries in Asia, La...

Indian pharma companies have recorded one more international success. Domestic pharma companies Cipla and Matrix have entered into a tie-up...